U.S. Healthcare Services Stock News

Some Bridgewater Bancshares, Inc. ( NASDAQ:BWB ) shareholders may be a little concerned to see that the CEO, Founder...

PepsiCo (PEP) sits at the center of a Consumer Staples story that now looks more complicated. Pricing power is fading, volume growth is flat, and earnings estimates have been revised lower. See our latest analysis for PepsiCo. PepsiCo’s recent price action has been soft, with the share price down about 11% over the past 90 days even though the 1 year total shareholder return is still positive at 4.64%. Recent brand partnerships with the Tampa Bay Buccaneers, product launches under Tostitos...

Merchants Bancorp (MBIN) drew fresh attention on 29 July 2026 after reporting second quarter 2026 earnings that exceeded Wall Street expectations, supported by loan servicing and asset management fees and higher net interest income. See our latest analysis for Merchants Bancorp. At a share price of $55.51, Merchants Bancorp has delivered a 67.30% year to date share price return and a 91.48% total shareholder return over the past year, suggesting momentum has been building around the company...

Outlook Therapeutics (OTLK) has just secured U.S. Food and Drug Administration approval for LYTENAVA, the first ophthalmic bevacizumab cleared for neovascular age-related macular degeneration in the United States. This development reshapes the company’s investment story. See our latest analysis for Outlook Therapeutics. At a share price of US$1.04, Outlook Therapeutics has seen a 90 day share price return of almost 3x, even after the 30 day share price return fell 34.59% and the 1 year total...

MainStreet Bancshares, Inc. ( NASDAQ:MNSB ) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend...

Orchid Island Capital (ORC) has drawn fresh attention after reporting second quarter 2026 results that shifted from a loss to net income of US$89.19 million, along with an update on its long running share repurchase program. See our latest analysis for Orchid Island Capital. At a share price of US$6.63, Orchid Island Capital has seen a 1-day share price return of 1.07%, while the 30-day and year to date share price returns are down 4.88% and 10.04% respectively. However, the 1-year total...

It's been a sad week for Varonis Systems, Inc. ( NASDAQ:VRNS ), who've watched their investment drop 13% to US$39.93 in...

Amalgamated Financial Corp. ( NASDAQ:AMAL ) is about to trade ex-dividend in the next three days. The ex-dividend date...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Las Vegas...

Orrstown Financial Services, Inc. ( NASDAQ:ORRF ) stock is about to trade ex-dividend in three days. Typically, the...

One of the biggest stories of last week was how Travelzoo ( NASDAQ:TZOO ) shares plunged 29% in the week since its...

We note that the Northeast Community Bancorp, Inc. ( NASDAQ:NECB ) Executive VP & CFO, Donald Hom, recently sold US$82k...

Huron Consulting Group Inc. ( NASDAQ:HURN ) investors will be delighted, with the company turning in some strong...

Even though Ovintiv Inc.'s ( NYSE:OVV ) recent earnings release was robust, the market didn't seem to notice. Investors...

It looks like Civista Bancshares, Inc. ( NASDAQ:CIVB ) is about to go ex-dividend in the next three days. The...

It's been a good week for Mondelez International, Inc. ( NASDAQ:MDLZ ) shareholders, because the company has just...

Solaris Energy Infrastructure has delivered a very large 5 year return, yet the stock now screens as overvalued on its earnings multiples and only a mixed picture on broader valuation checks. After a sharp pullback in recent weeks, investors are weighing a strong longer term share price record against signals that the current price may already embed a lot of good news. Over the last 5 years, Solaris Energy Infrastructure has returned about 6.7x, which sets a high bar for any further gains to...

As you might know, Commercial Bancgroup, Inc. ( NASDAQ:CBK ) just kicked off its latest second-quarter results with...

Amprius Technologies stock has delivered a 36.7% return over the past year, yet the current valuation checks and market multiples point to a picture that is not clearly cheap or clearly expensive. Over the last 12 months, Amprius Technologies is up 36.7%, which puts recent enthusiasm for the stock front and center for anyone thinking about valuation today. The key potential support for the valuation is whether Amprius Technologies can turn its technology and commercial progress into...

UniFirst (UNF) drew fresh attention after its stock closed at $293.60, with recent returns over the month and past 3 months standing out against its longer term performance profile. See our latest analysis for UniFirst. The recent pullback of 2.52% on the day sits against a stronger backdrop for UniFirst, with a 30-day share price return of 11.02% and year-to-date share price return of 51.65%. Over the same period, the 1-year total shareholder return of 72.83% and 3-year total shareholder...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Core Scientific stock has delivered a 61.1% return over the past year, yet the broader valuation checks currently lean toward the shares looking expensive rather than clearly cheap. A 61.1% one year gain highlights how strongly expectations have shifted for Core Scientific and raises the bar for what the current price already assumes. The long term AI infrastructure agreements with AMD can support confidence in future data center revenue, while heavy upfront investment and execution risk on...

A week ago, Incyte Corporation ( NASDAQ:INCY ) came out with a strong set of quarterly numbers that could potentially...

Over the last 7 days, the United States market has remained flat, yet it is up 17% over the past year with earnings expected to grow by 17% per annum over the next few years. In this environment, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on future growth prospects.